Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 2
1949 1
1951 1
1952 2
1954 2
1955 2
1957 1
1959 3
1960 2
1961 2
1963 3
1964 3
1965 3
1971 1
1973 1
1974 1
1975 1
1977 4
1978 8
1979 11
1980 10
1981 12
1982 2
1983 4
1984 5
1985 9
1986 8
1987 9
1988 8
1989 9
1990 6
1991 22
1992 15
1993 11
1994 28
1995 11
1996 15
1997 22
1998 26
1999 27
2000 31
2001 54
2002 64
2003 66
2004 96
2005 110
2006 121
2007 138
2008 146
2009 146
2010 198
2011 225
2012 265
2013 242
2014 302
2015 294
2016 319
2017 330
2018 383
2019 421
2020 471
2021 518
2022 423
2023 361
2024 162

Text availability

Article attribute

Article type

Publication date

Search Results

5,460 results

Results by year

Filters applied: . Clear all
Page 1
Oxycodone.
Kalso E. Kalso E. J Pain Symptom Manage. 2005 May;29(5 Suppl):S47-56. doi: 10.1016/j.jpainsymman.2005.01.010. J Pain Symptom Manage. 2005. PMID: 15907646 Free article. Review.
Oxycodone has been in clinical use since 1917. Parenteral oxycodone was used mainly for the treatment of acute postoperative pain whereas combinations, for example, oxycodone and acetaminophen, were used for moderate pain. ...Being an old drug, the basic phar …
Oxycodone has been in clinical use since 1917. Parenteral oxycodone was used mainly for the treatment of acute postoperative p …
Updated Clinical Pharmacokinetics and Pharmacodynamics of Oxycodone.
Kinnunen M, Piirainen P, Kokki H, Lammi P, Kokki M. Kinnunen M, et al. Clin Pharmacokinet. 2019 Jun;58(6):705-725. doi: 10.1007/s40262-018-00731-3. Clin Pharmacokinet. 2019. PMID: 30652261 Review.
Global oxycodone consumption has increased sharply during the last two decades, and, in 2008, oxycodone consumption surpassed that of morphine. As oxycodone was synthesized in 1916 and taken to clinical use a year later, it has not undergone the same approval …
Global oxycodone consumption has increased sharply during the last two decades, and, in 2008, oxycodone consumption surpassed …
The pharmacokinetics of oxycodone.
Lugo RA, Kern SE. Lugo RA, et al. J Pain Palliat Care Pharmacother. 2004;18(4):17-30. doi: 10.1300/j354v18n04_03. J Pain Palliat Care Pharmacother. 2004. PMID: 15760805 Review.
Oxycodone is among the most commonly used opioid analgesics for the relief of moderate-to-severe pain and is pharmacodynamically comparable to morphine. Oxycodone is available in the United States in oral dosage forms and controlled-release tablets. ...
Oxycodone is among the most commonly used opioid analgesics for the relief of moderate-to-severe pain and is pharmacodynamically comp …
Oxycodone, an opioid like the others?
Marie N, Noble F. Marie N, et al. Front Psychiatry. 2023 Dec 13;14:1229439. doi: 10.3389/fpsyt.2023.1229439. eCollection 2023. Front Psychiatry. 2023. PMID: 38152360 Free PMC article. Review.
Oxycodone is the most incriminated drug in the early years of the epidemic of opioid use disorder in USA (roughly 1999-2016). The number of preclinical articles on oxycodone is rapidly increasing. Several publications have already compared oxycodone with othe …
Oxycodone is the most incriminated drug in the early years of the epidemic of opioid use disorder in USA (roughly 1999-2016). The num …
Oxycodone: A Current Perspective on Its Pharmacology, Abuse, and Pharmacotherapeutic Developments.
Barrett JE, Shekarabi A, Inan S. Barrett JE, et al. Pharmacol Rev. 2023 Nov;75(6):1062-1118. doi: 10.1124/pharmrev.121.000506. Epub 2023 Jun 15. Pharmacol Rev. 2023. PMID: 37321860 Review.
Oxycodone, a semisynthetic derivative of naturally occurring thebaine, an opioid alkaloid, has been available for more than 100 years. ...Several concerns were expressed as early as the 1940s that oxycodone had significant abuse potential similar to heroin and morph …
Oxycodone, a semisynthetic derivative of naturally occurring thebaine, an opioid alkaloid, has been available for more than 100 years …
Oxycodone Therapy and CYP2D6 Genotype.
Kane M. Kane M. 2022 Oct 4. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–. 2022 Oct 4. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–. PMID: 36198024 Free Books & Documents. Review.
Oxycodone (brand names OxyContin, Roxicodone, Xtampza ER, and Oxaydo), is an opioid analgesic used for moderate to severe pain caused by various conditions for which alternative analgesic treatments are inadequate.(1) Oxycodone exerts its analgesic affects by bindin …
Oxycodone (brand names OxyContin, Roxicodone, Xtampza ER, and Oxaydo), is an opioid analgesic used for moderate to severe pain caused …
Revisiting Oxycodone Analgesia: A Review and Hypothesis.
Ruan X, Mancuso KF, Kaye AD. Ruan X, et al. Anesthesiol Clin. 2017 Jun;35(2):e163-e174. doi: 10.1016/j.anclin.2017.01.022. Epub 2017 Mar 14. Anesthesiol Clin. 2017. PMID: 28526158 Review.
Oxycodone, a semisynthetic opioid analgesic, is widely used in clinical practice. Oxycodone and morphine seem to be equally effective and equipotent; however, morphine is 10 times more potent than oxycodone when given epidurally. ...
Oxycodone, a semisynthetic opioid analgesic, is widely used in clinical practice. Oxycodone and morphine seem to be equally ef …
Oxycodone/Naloxone Prolonged Release: A Review in Severe Chronic Pain.
Kim ES. Kim ES. Clin Drug Investig. 2017 Dec;37(12):1191-1201. doi: 10.1007/s40261-017-0593-1. Clin Drug Investig. 2017. PMID: 29098567 Review.
Oral naloxone prevents oxycodone from binding to mu-receptors in the gastrointestinal (GI) tract, thereby counteracting opioid-induced constipation (OIC). In short-term (5- to 12-week) clinical trials of adults with moderate to severe, chronic pain and OIC (OXN3001, OXN300 …
Oral naloxone prevents oxycodone from binding to mu-receptors in the gastrointestinal (GI) tract, thereby counteracting opioid-induce …
Oxycodone-related deaths in Sweden 2006-2018.
Fugelstad A, Ågren G, Ramstedt M, Thiblin I, Hjelmström P. Fugelstad A, et al. Drug Alcohol Depend. 2022 May 1;234:109402. doi: 10.1016/j.drugalcdep.2022.109402. Epub 2022 Mar 11. Drug Alcohol Depend. 2022. PMID: 35306392 Free article.
Oxycodone-related deaths amounted to 10.0% of all opioid-related deaths. ...Only 15% had received treatment for SUD during the last year. CONCLUSION: Oxycodone-related deaths increased in Sweden between 2006 and 2018 in parallel to an increase in oxycodone pr …
Oxycodone-related deaths amounted to 10.0% of all opioid-related deaths. ...Only 15% had received treatment for SUD during the last y …
Oxycodone extended release capsules for the treatment of chronic pain.
Mercadante S. Mercadante S. Expert Rev Neurother. 2017 May;17(5):427-431. doi: 10.1080/14737175.2017.1302331. Epub 2017 Mar 10. Expert Rev Neurother. 2017. PMID: 28277802 Review.
Areas covered: The introduction of abuse-deterrent opioid formulations and continuous programs to improve opioid prescribing practices may limit the opioid abuse and its consequences. Oxycodone extended release capsules are an extended-release (ER), microsphere-in-capsule …
Areas covered: The introduction of abuse-deterrent opioid formulations and continuous programs to improve opioid prescribing practices may l …
5,460 results